Skip to content
TrackPodcasts
healthSep 23, 202538:11pending

The Latest Clinical Study on GLP-1 Receptor Agonists

About this episode

In this podcast, Dr. Seeds addresses a recent clinical study that advances the effectiveness of GLP-1 receptor agonists like semaglutide (trade name Ozempic) as an anti-aging treatment. 

Follow for more!

Instagram: @SSRPInstitute | @Redoxmedicalgroup

Youtube: Subscribe Here

Get every episode summarized

Each time Redox Revolution publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

The Latest Clinical Study on GLP-1 Receptor Agonists

Redox Revolution

0:00
38:11

More episodes

More from Redox Revolution

View all episodes →